Costamare Q3 Adjusted Earnings, Revenue Fall-June 2024-www.financetom.com

Costamare Q3 Adjusted Earnings, Revenue Fall

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Costamare Q3 Adjusted Earnings, Revenue Fall

Nov 4, 2025 6:17 AM

08:45 AM EST, 11/04/2025 (MT Newswires) -- Costamare ( CMRE ) reported Q3 adjusted earnings Tuesday of $0.81 per diluted share, down from $0.86 a year earlier.

Two analysts surveyed by FactSet expected $0.70.

Revenue for the quarter ended Sept. 30 was $225.2 million, down from $225.8 million a year earlier.

Two analysts polled by FactSet expected $197.9 million.

Shares of Costamare ( CMRE ) were up 0.6% in recent Tuesday premarket activity.

Previous page： Frequency Electronics Wins $7 Million Contract to Support Lunar Space Mission Next page： Chinese drugmaker Hengrui's quarterly profit misses forecasts amid generic drug business squeeze

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Frequency Electronics Wins $7 Million Contract to Support Lunar Space Mission

Mar 25, 2026

09:31 AM EDT, 03/25/2026 (MT Newswires) -- Frequency Electronics ( FEIM ) said Wednesday it was awarded a roughly $7 million contract to deliver atomic clocks to assist with position, navigation and timing for a lunar space mission. Shares of the company were up more than 2% in early trading Wednesday. ...

Chinese drugmaker Hengrui's quarterly profit misses forecasts amid generic drug business squeeze

Mar 25, 2026

SHANGHAI, March 25 (Reuters) - Jiangsu Hengrui Pharmaceuticals, China's biggest drugmaker by market value, reported fourth-quarter profit below market expectations on Wednesday, as income from business development deals has failed to appear. The specialist in oncology, neurology, immunology, respiratory, metabolic and cardiovascular drugs has expanded licensing deals and developed more innovative drugs amid Beijing's centralised bulk buying programmes, which have...

Blueprint Expands Capital Markets Capabilities with Acquisition of HUD Lending Platform

Mar 25, 2026

CHICAGO, March 25, 2026 /PRNewswire/ -- Blueprint Healthcare Real Estate Advisors (Blueprint), the leading advisor in healthcare real estate investment sales, is pleased to announce a significant expansion of its Capital Markets practice through the integration of FHA/HUD lending and servicing capabilities, enabled by the acquisition of the FHA/HUD lending platform from MidCap Financial Services, LLC. This move allows...

Ex-Google exec Matt Brittin named new BBC boss

Mar 25, 2026

LONDON, March 25 (Reuters) - Britain's BBC on Wednesday named former Google executive Matt Brittin as director general, replacing Tim Davie who quit last year. Brittin, who joined Google in 2007 as head of UK and Ireland before becoming EMEA president in 2014 and stepped down in 2024, will take on the role from May 18. ...